Violeta Deyanira Álvarez-Jiménez
YOU?
Author Swipe
View article: Convalescent Plasma to Treat COVID-19: A Two-Center, Randomized, Double-Blind Clinical Trial
Convalescent Plasma to Treat COVID-19: A Two-Center, Randomized, Double-Blind Clinical Trial Open
Background: The use of convalescent plasma (CP) has been considered for its immunological mechanisms that could benefit patients in moderate and severe stages of COVID-19. This study evaluated the safety and efficacy of the use of donor CP…
View article: Convalescent Plasma to Treat Covid-19: a Randomized Double Blind 2 Centers Trial
Convalescent Plasma to Treat Covid-19: a Randomized Double Blind 2 Centers Trial Open
In SARS-CoV-2, there is an overactivation of the immune system that triggers systemic hyperinflammation that causes lung damage; therefore, the use of convalescent plasma (CP) has been considered for its immunological mechanisms that could…